The successful use of tuberculin in the treatment for ocular tuberculosis has been challenged by a number of internists as well as by ophthalmologists. There is undoubtedly some justification for this skepticism, as it is unanimously agreed that tuberculin, if improperly given, can do far more harm to the eye than good. For a number of years I have been interested in the treatment for this disease, and the results of the treatment of a selected group of patients have been so gratifying that their publication might be instructive.
During the last quarter of a century the attitude of ophthalmologists toward obscure ocular lesions has changed to a great degree. Vague terms, such as rheumatic eye disease and so-called idiopathic disease of the sclera, have been properly discarded because of the newer knowledge of disease. Verhoeff1 went so far as to say that "ordinary scleritis and
GAY LN. THE TREATMENT OF OCULAR TUBERCULOSIS WITH TUBERCULIN. Arch Ophthalmol. 1930;3(3):259–287. doi:10.1001/archopht.1930.00810050011001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: